Skip to main content
FDA Shortage Check

Is Phenergan (Promethazine Hydrochloride Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Phenergan: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Hikma Pharmaceuticals USA, Inc., Oct 14, 2026
DRUG
Phenergan
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Nov 21, 2023
LAST FDA UPDATE
Oct 14, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 10 presentations: 5 unavailable · 0 limited · 5 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Promethazine Hydrochloride Injection. 10 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Hikma Pharmaceuticals USA, Inc.8 presentations · 4 unavailable · 4 available or not stated

Contact (FDA's listing): 800-631-2174

  • 25 mg/1 mL

    Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)

    Estimated recovery: TBD

    NDC 0641-6084-25Reverified

    Unavailable

  • 50 mg/1 mL

    Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)

    Estimated recovery: TBD

    NDC 0641-6085-25Reverified

    Unavailable

  • 25 mg/1 mL

    Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)

    Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.

    NDC 0641-1495-35Revised

    Unavailable

  • 50 mg/1 mL

    Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)

    Estimated recovery: TBD

    NDC 0641-0929-25Revised

    Unavailable

  • 25 mg/1 mL

    Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6082-25Revised

    Available

  • 50 mg/1 mL

    Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6083-25Revised

    Available

  • 25 mg/1 mL

    Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-0928-25Revised

    Available

  • 50 mg/1 mL

    Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-1496-35Reverified

    Available

XGen Pharmaceuticals DJB, Inc.2 presentations · 1 unavailable · 1 available or not stated

Contact (FDA's listing): 866-390-4411

  • 50 mg/1 mL

    Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)

    Estimated recovery: TBD

    NDC 39822-5550-6Reverified

    Unvailable

  • 25 mg/1 mL

    Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)

    NDC 39822-5525-3Reverified

    Available

What the manufacturers told FDA

  • Hikma Pharmaceuticals USA, Inc. · ‘Estimated recovery: TBD’ · updated Oct 2026
  • XGen Pharmaceuticals DJB, Inc. · ‘Estimated recovery: TBD’ · updated Sep 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Phenergan in shortage?
Yes. As of Oct 24, 2026, FDA lists Promethazine Hydrochloride Injection as currently in shortage: 10 presentations, 5 unavailable and 0 limited.
When will the Phenergan shortage end?
FDA gives no end date. 4 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Phenergan?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.